1. The First Question Is What Triggered the License Investigation
The Office of Professional Medical Conduct (OPMC) investigates professional misconduct involving physicians, physician assistants, and specialist assistants. New York Education Law § 6530 identifies numerous forms of misconduct, including fraud, certain forms of negligence or incompetence, practicing beyond an authorized scope, and other specified conduct. That broad framework makes the source of the investigation important: the same notice from OPMC can require a very different factual review depending on whether the underlying concern arose from patient care, billing, prescribing, or a hospital proceeding.
The Preliminary Stage Can Shape What Comes Next
An investigation is not itself a finding of misconduct. Before deciding how to respond, the physician should identify the conduct under review, the relevant time period, the patients or records involved, and any related proceeding already underway.
Under Public Health Law § 230, the investigative process can include an interview at which the licensee may be represented by counsel. Current law generally requires written notice before that interview identifying the conduct and issues under investigation. Records and written submissions prepared at this stage may later become part of the material considered in deciding whether the matter should proceed.
Broader licensing and enforcement questions may also overlap with healthcare compliance and regulatory matters.
2. Patient Complaints Require More Than a Review of the Medical Outcome
A poor clinical result does not by itself establish professional misconduct. The relevant question is whether the physician’s conduct satisfies a statutory ground for discipline. In a patient-initiated matter, the record may therefore matter more than the patient’s dissatisfaction alone: contemporaneous charts, informed-consent documentation, communications, follow-up instructions, and the clinical reasoning reflected in the file can change how the allegation is evaluated.
Preserve the Record Rather Than Reconstruct It
Existing medical records should be preserved as they were maintained in the ordinary course. An investigation is not the time to rewrite a chart so that it better explains an earlier decision.
If a response requires additional explanation, it should remain distinct from the original clinical record. That distinction allows the physician to explain the medical reasoning without creating confusion about when a particular entry was made.
3. Billing and Prescribing Concerns Can Create Separate Legal Tracks
A billing discrepancy and an allegedly improper prescription are not interchangeable forms of misconduct. Billing matters may raise questions about coding, documentation, reimbursement, or fraud. Prescribing matters may focus on medical necessity, clinical judgment, controlled substances, or recordkeeping. Either issue can reach OPMC while also producing a separate federal or payer investigation.
Billing Error Is Not the Same As Fraud
A coding error does not automatically establish intentional fraud. The legal analysis depends on the statute or rule at issue, what the records show, who made the relevant billing decisions, and what level of knowledge the government would have to prove.
When a billing dispute expands into an allegation of knowingly false claims or other intentional misconduct, the licensing analysis should remain separate from any health care fraud defense. A resolution on one track does not necessarily resolve the other.
DEA Proceedings Are Federal, Not Part of the State Licensing Process
Controlled-substance prescribing can attract both OPMC scrutiny and DEA attention, but the two authorities exercise different powers. Federal rules governing controlled-substance prescriptions include the requirement that a prescription be issued for a legitimate medical purpose in the usual course of professional practice.
Clinical notes, prescription histories, monitoring data, examinations, treatment plans, and documented reasoning may therefore matter in more than one proceeding. A response prepared for a licensing investigation should be reviewed with any separate DEA or federal exposure in mind rather than assuming that the agencies are conducting a single case.
4. Sexual Misconduct and Supervision Allegations Turn on Different Evidence
Boundary allegations often involve competing accounts, contemporaneous communications, appointment records, witnesses, and other corroborating evidence. Supervision cases focus instead on what duties were delegated, what oversight was required, and what the supervising practitioner actually did. Treating both as generic “professional misconduct” can obscure the facts that determine the result.
Criminal Exposure Requires a Separate Defense Analysis
Some allegations may also lead to a criminal investigation. OPMC proceedings and criminal cases serve different purposes and apply different procedures.
Statements made to licensing investigators can therefore have consequences outside the administrative matter. Where federal investigators become involved, the issues may also intersect with federal criminal defense. The existence of a parallel investigation does not mean the same response strategy should be used in both.
Supervision Is Not Automatic Liability for Another Practitioner’S Error
An error by a supervised practitioner does not, by itself, establish misconduct by the supervising physician. The inquiry should focus on the applicable supervision requirements, the delegated task, the physician’s actual oversight, and the circumstances of the underlying care.
Protocols, schedules, communications, and supervision records may help show what responsibilities were assigned and how they were carried out.
5. Hospital Peer Review Can Extend Beyond the Hospital
A hospital credentialing or peer review matter can have consequences outside the institution. Federal NPDB rules require reporting of certain adverse clinical privileges actions, including qualifying professional review actions lasting more than 30 days and certain surrenders or restrictions of privileges while an investigation is pending. The investigation itself is not automatically reportable, so the precise action taken matters.
A Resignation or Restriction May Have Reporting Consequences
A physician considering resignation, nonrenewal, or a restriction of privileges during an investigation should examine whether the action could qualify for NPDB reporting before agreeing to it.
That federal reporting question is distinct from whether OPMC later investigates the underlying conduct. Hospital documents, peer review findings, and privilege decisions may nevertheless become relevant to a licensing matter, which makes the timing and wording of an institutional resolution significant.
6. A Settlement Should Be Reviewed Beyond the Immediate License Terms
A disciplinary matter may resolve through an agreed disposition rather than a contested hearing, depending on the procedural posture and agency approval. The important question is not simply whether the physician can avoid a hearing. Proposed admissions, practice restrictions, monitoring requirements, probation terms, and reporting consequences can affect clinical work well after the investigation ends.
One Resolution May Not End the Other Proceedings
A state licensing resolution does not automatically dispose of DEA, hospital, payer, civil, or criminal matters. Before accepting proposed terms, a physician should identify which factual admissions are being made, what restrictions follow, and whether another authority could use the same documents or findings.
That cross-proceeding analysis is where a medical license investigation differs from a routine licensing question. A matter involving several regulatory tracks may also require review within the broader framework of healthcare laws and regulatory enforcement.
30 Sep, 2026
